The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ProMIS Neurosciences Inc shares valued at $14,929 were purchased by Milbury Max A. on Oct 03 ’25. At $0.49 per share, Milbury Max A. acquired 30,392 shares. The insider’s holdings grew to 45,389 shares worth approximately $18609.489999999998 following the completion of this transaction.
Also, Cashman Neil purchased 15,000 shares, netting a total of over 14,595 in proceeds. Following the buying of shares at $0.97 each, the insider now holds 16,617 shares.
Analyzing PMN Stock Performance
On last trading session, ProMIS Neurosciences Inc [NASDAQ: PMN] rose 3.95% to $0.41. The stock’s lowest price that day was $0.3956, but it reached a high of $0.451 in the same session. During the last five days, there has been a surge of approximately 0.17%. Over the course of the year, ProMIS Neurosciences Inc shares have dropped approximately -61.63%. Shares of the company reached a 52-week high of $1.5900 on 07/21/25 and a 52-week low of $0.3600 on 11/07/25.
Support And Resistance Levels for ProMIS Neurosciences Inc (PMN)
According to the 24-hour chart, there is a support level at 0.3871, which, if violated, would cause prices to drop to 0.3637. In the upper region, resistance lies at 0.4425. The next price resistance is at 0.4745. RSI (Relative Strength Index) is 44.96 on the 14-day chart, showing neutral technical sentiment.
Is ProMIS Neurosciences Inc subject to short interest?
Stocks of ProMIS Neurosciences Inc saw a sharp steep in short interest on 2025-10-31 dropping by 43145.0 shares to 0.28 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 0.32 million shares. A decline of -15.56% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.36 of the overall float, the days-to-cover ratio (short ratio) decline to 0.36.
Which companies own the most shares of ProMIS Neurosciences Inc (PMN)?
In terms of ProMIS Neurosciences Inc share price expectations, FactSet research, analysts set an average price target of 4 in the next 12 months, up nearly 900.0% from the previous closing price of $0.4. Analysts anticipate ProMIS Neurosciences Inc stock to reach 4 by 2025, with the lowest price target being 4.
